HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.430
0.00 (0.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
HCW Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -38.37 | -24.99 | -14.9 | -12.86 | -5.8 | -7.29 |
| Depreciation & Amortization | 0.93 | 1.14 | 0.72 | 0.54 | 0.57 | 0.42 |
| Other Amortization | - | - | - | - | 0.02 | - |
| Loss (Gain) From Sale of Investments | -0.04 | -0.26 | 0.19 | 0.07 | - | - |
| Stock-Based Compensation | 0.97 | 1 | 1.12 | 0.36 | 0.02 | 0 |
| Provision & Write-off of Bad Debts | 5.25 | 5.25 | - | - | - | - |
| Other Operating Activities | -0 | -0 | 0 | -0.54 | - | - |
| Change in Accounts Receivable | 0.05 | -1.12 | -0.28 | 2.37 | -2.5 | - |
| Change in Accounts Payable | 12.3 | 1.62 | 0.42 | 1.89 | -0.63 | 0.77 |
| Change in Other Net Operating Assets | 0.96 | -5.14 | 2.35 | -2.8 | -2.12 | -0.66 |
| Operating Cash Flow | -17.95 | -22.51 | -10.39 | -10.98 | -10.43 | -6.77 |
| Capital Expenditures | -4.46 | -6.2 | -10.28 | -0.05 | -0.19 | -1.46 |
| Investment in Securities | 10 | 10 | 24.98 | -34.97 | - | - |
| Other Investing Activities | - | - | - | - | - | 0 |
| Investing Cash Flow | 5.54 | 3.8 | 14.71 | -35.02 | -0.19 | -1.46 |
| Short-Term Debt Issued | - | - | - | - | 0.56 | - |
| Long-Term Debt Issued | - | - | 6.45 | - | - | - |
| Total Debt Issued | 3.7 | - | 6.45 | - | 0.56 | - |
| Long-Term Debt Repaid | - | -0.04 | - | - | - | - |
| Net Debt Issued (Repaid) | 3.6 | -0.04 | 6.45 | - | 0.56 | - |
| Issuance of Common Stock | 2.52 | 0.02 | 0.02 | 56.03 | 0.01 | 0.06 |
| Other Financing Activities | - | - | -0.19 | -6.76 | - | - |
| Financing Cash Flow | 6.12 | -0.01 | 6.27 | 49.27 | 11.72 | 13.45 |
| Net Cash Flow | -6.29 | -18.73 | 10.6 | 3.27 | 1.1 | 5.22 |
| Free Cash Flow | -22.41 | -28.72 | -20.66 | -11.02 | -10.62 | -8.23 |
| Free Cash Flow Margin | -571.22% | -1010.51% | -307.36% | - | -258.99% | - |
| Free Cash Flow Per Share | -0.61 | -0.80 | -0.58 | -0.59 | -2.24 | -1.92 |
| Cash Interest Paid | 0.25 | 0.28 | 0.13 | - | - | - |
| Levered Free Cash Flow | -6.03 | -15.29 | -15.73 | -5.68 | -6.86 | - |
| Unlevered Free Cash Flow | -5.87 | -15.12 | -15.65 | -5.68 | -6.88 | - |
| Change in Net Working Capital | -19.93 | -5.02 | -2.21 | -1.81 | 3.65 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.